GeoVax Labs Inc
GOVXLatest QuantConomy context for GOVX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
GeoVax Labs Inc
QuantConomy has a structured record for GOVX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- GOVX
- Name
- GeoVax Labs Inc
- Coverage
- 3 market/data records
- Sources
- fmp alpaca alphavantage sec nasdaq openfigi
Recent signals for GOVX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| delisting | very bearish | 75 | Jul 10, 08:10 PM | GOVX filed 8-K: Delisting Notice - 1 material event - [strong very bearish signal] |
| net income change | very bullish | 76 | May 14, 12:00 AM | GOVX (Q1 2026, net income): grew 75.5% (-$21.46M → -$5.26M). [sequential period basis, very bullish signal] |
| operating income change | very bullish | 76 | May 14, 12:00 AM | GOVX (Q1 2026, operating income): grew 75.6% (-$21.64M → -$5.27M). [sequential period basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
OWNERSHIP signals are experimental: historical 13D/G coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| GOVX | NASDAQ | fmp | GeoVax Labs, Inc. |
| GOVX | NASDAQ | alpaca | GeoVax Labs, Inc. Common Stock |
| GOVX | NASDAQ | alphavantage | Geovax Labs Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Morgan Jayne | Insider | grant | 6,000 | — | — | 4 on EDGAR |
| Jun 17, 2026 | CHASE RANDAL D | Insider | grant | 6,000 | — | — | 4 on EDGAR |
| Jun 17, 2026 | MCNALLY ROBERT T | Insider | grant | 6,000 | — | — | 4 on EDGAR |
| Jun 17, 2026 | Reynolds Mark | CFO | grant | 17,600 | — | — | 4 on EDGAR |
| Jun 17, 2026 | DODD DAVID A | President, CEO | grant | 29,300 | — | — | 4 on EDGAR |
| Jun 17, 2026 | Lemerond Nicole | Insider | grant | 6,000 | — | — | 4 on EDGAR |
| Jun 17, 2026 | NEWMAN MARK J | Chief Scientific Officer | grant | 17,600 | — | — | 4 on EDGAR |
| Jun 17, 2026 | SPENCER JOHN N JR | Insider | grant | 6,000 | — | — | 4 on EDGAR |
| Jun 17, 2026 | Sharkey John W. | VP, Business Development | grant | 17,600 | — | — | 4 on EDGAR |
| Jun 17, 2026 | Kollintzas Dean G | Insider | grant | 6,000 | — | — | 4 on EDGAR |
| Jun 17, 2026 | McKee Kelly T. Jr. | Chief Medical Officer | grant | 17,600 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query GOVX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access